Skip to Main Content

Paper Details

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.
Nat Commun
40
2016
R179X, R179X variant, RNF186, human, inflammatory bowel disease, patients, protein, ring finger E3 ligase, rs36095412, single-exon, ulcerative colitis
Author NameAffiliation
Manuel A RivasBroad Institute of MIT and Harvard
Manuel A RivasMassachusetts General Hospital, Harvard Medical School
Manuel A RivasBroad Institute of MIT and Harvard
Manuel A RivasMassachusetts General Hospital, Harvard Medical School
Patrick SulemAmgen Inc.
Christine StevensBroad Institute of MIT and Harvard
Philippe GoyetteResearch Center, Montreal Heart Institute
Daniel F GudbjartssonAmgen Inc.
Daniel F GudbjartssonUniversity of Iceland
Unnur ThorsteinsdottirAmgen Inc.
Unnur ThorsteinsdottirUniversity of Iceland
Unnur ThorsteinsdottirAmgen Inc.
Unnur ThorsteinsdottirUniversity of Iceland
Mitja I KurkiBroad Institute of MIT and Harvard
Mitja I KurkiMassachusetts General Hospital, Harvard Medical School
Mauro D'AmatoKarolinska Institutet
Mauro D'AmatoBioCruces Health Research Institute and IKERBASQUE, Basque Foundation for Science
Jonas HalfvarsonOrebro University
Monkol LekBroad Institute of MIT and Harvard
Monkol LekMassachusetts General Hospital, Harvard Medical School
Beryl B CummingsBroad Institute of MIT and Harvard
Beryl B CummingsMassachusetts General Hospital, Harvard Medical School
Taru TukiainenBroad Institute of MIT and Harvard
Taru TukiainenMassachusetts General Hospital, Harvard Medical School
Talin HarituniansF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Talin HarituniansCedars-Sinai Medical Center
Ashwin N AnanthakrishnanMassachusetts General Hospital, Harvard Medical School
Ashwin N AnanthakrishnanHarvard Medical School
Daniel G MacArthurBroad Institute of MIT and Harvard
Daniel G MacArthurMassachusetts General Hospital, Harvard Medical School
Daniel G MacArthurBroad Institute of MIT and Harvard
Daniel G MacArthurMassachusetts General Hospital, Harvard Medical School
Benjamin M NealeBroad Institute of MIT and Harvard
Benjamin M NealeMassachusetts General Hospital, Harvard Medical School
Benjamin M NealeBroad Institute of MIT and Harvard
Benjamin M NealeMassachusetts General Hospital, Harvard Medical School
Carl A AndersonWellcome Trust Sanger Institute
Steven R BrantJohns Hopkins University
Steven R BrantBloomberg School of Public Health, Johns Hopkins University
Richard H DuerrUniversity of Pittsburgh School of Medicine
Richard H DuerrUniversity of Pittsburgh Graduate School of Public Health
Mark S SilverbergMount Sinai Hospital
Judy H ChoYale School of Medicine
Aarno PalotieBroad Institute of MIT and Harvard
Aarno PalotieMassachusetts General Hospital, Center for Human Genetic Research
Aarno PalotieInstitute for Molecular Medicine Finland, University of Helsinki
Aarno PalotieMassachusetts General Hospital, Harvard Medical School
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Dermot P B McGovernCedars-Sinai Medical Center
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
  • 1 - 50

Datasets